| Up
2006P-0086:
To declare that the drug product, Butalbital, 50 mg and acetaminophen,
300 mg Tablets, is suitable for consideration in an abbreviated
new drug application (ANDA)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
| |
CP1 |
|
02/23/2006
|
|
02/23/2006
|
|
Private Industry
|
|
Lachman Consultant
Services, Inc. |
|
|
|
|
|
|
|
Table
of Contents |
|
|
|
| |
Signature: |
|
Robert W. Pollock
|
|
| |
| |
ACK1 |
|
02/23/2006
|
|
02/23/2006
|
|
Federal Government |
|
HFA-305 to LachmanConsultant
Services, Inc. |
|
|
|
|
|
|
|
pdf |
|
|
|
| |
|
|
Signature: |
|
Jennie C. Butler
|
|
| |
| |
EC1 |
|
08/02/2006
|
|
07/31/2006
|
|
Individual Consumer
|
|
Mr. Dave Lowe
|
|
|
|
|
|
|
|
htm
Attachment |
|
|
|
| |
| |
PAV1 |
|
08/21/2006
|
|
08/21/2006
|
|
Federal Government |
|
FDA/CDER to
Lachman Consultant Services, Inc. |
|
|
|
|
|
|
|
pdf |
|
|
|
| |
|
|
Signature: |
|
Gary J. Buehler |
|
Top | Up
Page last updated
September 19, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
